quantisnow
FeedTopReportsPricing
⌘K
Live feed
15:17:00·81d
PRRelease
Pharming Group N.V. ADS each representing 10 logo

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

PHAR· Pharming Group N.V. ADS each representing 10
Health Care
Original source

Companies

  • PHAR
    Pharming Group N.V. ADS each representing 10
    Health Care

Recent analyst ratings

  • Apr 10UpdateCanaccord Genuity$37.00
  • Dec 9UpdateJefferies$14.00

Related

  • PR1d
    Pharming Group to report first quarter 2026 financial results and provide business update on May 7
  • SEC7d
    SEC Form 6-K filed by Pharming Group N.V. ADS each representing 10
  • SEC10d
    Amendment: SEC Form 20-F/A filed by Pharming Group N.V. ADS each representing 10
  • ANALYST13d
    Canaccord Genuity initiated coverage on Pharming Group N.V. with a new price target
  • PR17d
    Pharming Group to participate in April investor conferences
  • SEC22d
    SEC Form 6-K filed by Pharming Group N.V. ADS each representing 10
  • SEC22d
    SEC Form 20-F filed by Pharming Group N.V. ADS each representing 10
  • SEC27d
    SEC Form 6-K filed by Pharming Group N.V. ADS each representing 10
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022